Literature DB >> 22008826

Interaural comparison of spiral ganglion cell counts in profound deafness.

Mohammad Seyyedi1, Donald K Eddington, Joseph B Nadol.   

Abstract

OBJECTIVES: This study is designed to measure the degree to which spiral ganglion cell (SGC) survival in the left and right ears is similar in profoundly hearing-impaired human patients with symmetric (right/left) etiology and sensitivity. This is of interest because a small difference between ears would imply that one ear could be used as a control ear in temporal bone studies evaluating the impact on SGC survival of a medical intervention in the other ear.
MATERIALS AND METHODS: Forty-two temporal bones from 21 individuals with bilaterally symmetric profound hearing impairment were studied. Both ears in each individual were impaired by the same etiology. Rosenthal's canal was reconstructed in two dimensions and segmental and total SGCs were counted. Correlation analysis and t-tests were used to compare segmental and total counts of left and right ears. Statistical power calculations illustrate how the results can be used to estimate the effect size (right/left difference in SGC count) that can be reliably identified as a function of sample size.
RESULTS: Left counts (segmental and total) were significantly correlated with those in the right ears (p < 0.01) and the coefficients of determination for segments 1 to 4 and total count were respectively 0.64, 0.91, 0.93, 0.91 and 0.98. The hypothesis that mean segmental and total counts of right and left are the same could not be rejected by paired t-test.
CONCLUSION: The variance in the between-ear difference across the temporal bones studied indicates that useful effect sizes can be reliably identified using subject numbers that are practical for temporal bone studies. For instance, there is 95% likelihood that an interaural difference in SGC count of approximately 1000 cells associated with a treatment/manipulation of one ear will be reliably detected in a bilaterally-symmetric profound hearing loss population of temporal bones from approximately 10 subjects.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22008826      PMCID: PMC3230694          DOI: 10.1016/j.heares.2011.10.002

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  10 in total

1.  Temporal bone anomaly proposed as a major criteria for diagnosis of CHARGE syndrome.

Authors:  J Amiel; T Attieé-Bitach; R Marianowski; V Cormier-Daire; V Abadie; D Bonnet; M Gonzales; S Chemouny; F Brunelle; A Munnich; Y Manach; S Lyonnet
Journal:  Am J Med Genet       Date:  2001-03-01

2.  Techniques for study of cochlear function and pathology in experimental animals; development of the anatomical frequency scale for the cat.

Authors:  H F SCHUKNECHT
Journal:  AMA Arch Otolaryngol       Date:  1953-10

3.  Effect of cochlear implantation on residual spiral ganglion cell count as determined by comparison with the contralateral nonimplanted inner ear in humans.

Authors:  Aayesha M Khan; Ophir Handzel; Doris Damian; Donald K Eddington; Joseph B Nadol
Journal:  Ann Otol Rhinol Laryngol       Date:  2005-05       Impact factor: 1.547

4.  Quantification of human spiral ganglion cells by serial section reconstruction and segmental density estimates.

Authors:  J B Nadol
Journal:  Am J Otolaryngol       Date:  1988 Mar-Apr       Impact factor: 1.808

5.  Temporal bone removal at autopsy. Preparation and uses.

Authors:  H Schuknecht
Journal:  Arch Otolaryngol       Date:  1968-02

6.  Multichannel cochlear implants: relation of histopathology to performance.

Authors:  Jose N Fayad; Fred H Linthicum
Journal:  Laryngoscope       Date:  2006-08       Impact factor: 3.325

7.  Histopathology of profound sensorineural deafness.

Authors:  R Hinojosa; M Marion
Journal:  Ann N Y Acad Sci       Date:  1983       Impact factor: 5.691

8.  Survival of spiral ganglion cells in profound sensorineural hearing loss: implications for cochlear implantation.

Authors:  J B Nadol; Y S Young; R J Glynn
Journal:  Ann Otol Rhinol Laryngol       Date:  1989-06       Impact factor: 1.547

9.  Spectrum of hearing disorders and their management in children with CHARGE syndrome.

Authors:  Susan Arndt; Roland Laszig; Rainer Beck; Christian Schild; Wolfgang Maier; Ralf Birkenhäger; Stefanie Kroeger; Thomas Wesarg; Antje Aschendorff
Journal:  Otol Neurotol       Date:  2010-01       Impact factor: 2.311

10.  Ganglion cell populations in normal and pathological human cochleae. Implications for cochlear implantation.

Authors:  J Otte; H F Schunknecht; A G Kerr
Journal:  Laryngoscope       Date:  1978-08       Impact factor: 3.325

  10 in total
  5 in total

1.  Cochlear neuropathy in human presbycusis: Confocal analysis of hidden hearing loss in post-mortem tissue.

Authors:  Lucas M Viana; Jennifer T O'Malley; Barbara J Burgess; Dianne D Jones; Carlos A C P Oliveira; Felipe Santos; Saumil N Merchant; Leslie D Liberman; M Charles Liberman
Journal:  Hear Res       Date:  2015-05-19       Impact factor: 3.208

2.  Within-subject comparison of word recognition and spiral ganglion cell count in bilateral cochlear implant recipients.

Authors:  Mohammad Seyyedi; Lucas M Viana; Joseph B Nadol
Journal:  Otol Neurotol       Date:  2014-09       Impact factor: 2.311

Review 3.  Neurocognitive factors in sensory restoration of early deafness: a connectome model.

Authors:  Andrej Kral; William G Kronenberger; David B Pisoni; Gerard M O'Donoghue
Journal:  Lancet Neurol       Date:  2016-03-12       Impact factor: 44.182

4.  Effect of monopolar and bipolar electric stimulation on survival and size of human spiral ganglion cells as studied by postmortem histopathology.

Authors:  Mohammad Seyyedi; Donald K Eddington; Joseph B Nadol
Journal:  Hear Res       Date:  2013-05-06       Impact factor: 3.208

5.  Preservation of Cells of the Organ of Corti and Innervating Dendritic Processes Following Cochlear Implantation in the Human: An Immunohistochemical Study.

Authors:  Takefumi Kamakura; Jennifer T O'Malley; Joseph B Nadol
Journal:  Otol Neurotol       Date:  2018-03       Impact factor: 2.311

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.